ABRDN HEALTHCARE OPPORT (THQ) Fundamental Analysis & Valuation
NYSE:THQ • US8791051043
Current stock price
18.56 USD
-0.1 (-0.54%)
Last:
This THQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. THQ Profitability Analysis
1.1 Basic Checks
- THQ had negative earnings in the past year.
- In the past year THQ had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: THQ reported negative net income in multiple years.
- Of the past 5 years THQ 4 years had a positive operating cash flow.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.86% | ||
| ROE | -15.52% | ||
| ROIC | N/A |
ROA(3y)3.1%
ROA(5y)3.38%
ROE(3y)3.65%
ROE(5y)4.11%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- THQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. THQ Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, THQ has about the same amount of shares outstanding.
- Compared to 5 years ago, THQ has less shares outstanding
- The debt/assets ratio for THQ is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.11 indicates that THQ is not a great score, but indicates only limited risk for bankruptcy at the moment.
- THQ has a debt to FCF ratio of 2.56. This is a good value and a sign of high solvency as THQ would need 2.56 years to pay back of all of its debts.
- THQ has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.56 | ||
| Altman-Z | 2.11 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- THQ has a Current Ratio of 1.00. This is a normal value and indicates that THQ is financially healthy and should not expect problems in meeting its short term obligations.
- A Quick Ratio of 1.00 indicates that THQ should not have too much problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. THQ Growth Analysis
3.1 Past
- THQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.22%.
- THQ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.29%.
- The Revenue has been decreasing by -0.99% on average over the past years.
EPS 1Y (TTM)-160.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-181.25%
Revenue 1Y (TTM)-10.29%
Revenue growth 3Y5%
Revenue growth 5Y-0.99%
Sales Q2Q%-20.58%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. THQ Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for THQ. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.74 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. THQ Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 10.67%, THQ is a good candidate for dividend investing.
- Compared to an average S&P500 Dividend Yield of 1.80, THQ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.67% |
5.2 History
- On average, the dividend of THQ grows each year by 9.85%, which is quite nice.
- THQ has been paying a dividend for at least 10 years, so it has a reliable track record.
- As THQ did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)9.85%
Div Incr Years2
Div Non Decr Years9
5.3 Sustainability
- The earnings of THQ are negative and hence is the payout ratio. THQ will probably not be able to sustain this dividend level.
DP-76.52%
EPS Next 2YN/A
EPS Next 3YN/A
THQ Fundamentals: All Metrics, Ratios and Statistics
NYSE:THQ (5/1/2026, 8:04:00 PM)
18.56
-0.1 (-0.54%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.3%
Inst Owner Change-0.94%
Ins Owners0%
Ins Owner Change0%
Market Cap769.13M
Revenue(TTM)21.53M
Net Income(TTM)-115.00M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio0.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.67% |
Yearly Dividend2.15
Dividend Growth(5Y)9.85%
DP-76.52%
Div Incr Years2
Div Non Decr Years9
Ex-Date04-22 2026-04-22 (0.18)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 35.72 | ||
| P/FCF | 8.74 | ||
| P/OCF | 8.74 | ||
| P/B | 1.04 | ||
| P/tB | 1.04 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.12
FCFY11.44%
OCF(TTM)2.12
OCFY11.44%
SpS0.52
BVpS17.86
TBVpS17.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.86% | ||
| ROE | -15.52% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 408.73% |
ROA(3y)3.1%
ROA(5y)3.38%
ROE(3y)3.65%
ROE(5y)4.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.56 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.11 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-181.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.29%
Revenue growth 3Y5%
Revenue growth 5Y-0.99%
Sales Q2Q%-20.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.82%
FCF growth 3Y16.54%
FCF growth 5Y6.74%
OCF growth 1Y12.82%
OCF growth 3Y16.54%
OCF growth 5Y6.74%
ABRDN HEALTHCARE OPPORT / THQ Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ABRDN HEALTHCARE OPPORT (THQ) stock?
ChartMill assigns a fundamental rating of 2 / 10 to THQ.
Can you provide the valuation status for ABRDN HEALTHCARE OPPORT?
ChartMill assigns a valuation rating of 0 / 10 to ABRDN HEALTHCARE OPPORT (THQ). This can be considered as Overvalued.
How profitable is ABRDN HEALTHCARE OPPORT (THQ) stock?
ABRDN HEALTHCARE OPPORT (THQ) has a profitability rating of 1 / 10.
How financially healthy is ABRDN HEALTHCARE OPPORT?
The financial health rating of ABRDN HEALTHCARE OPPORT (THQ) is 3 / 10.